Pieris Pharmaceuticals Inc (NASDAQ:PIRS) stock continues to trade higher in the opening session after soaring 104% yesterday. Moreover, the stock made another multi-year high in Wednesday’s trading session.
As of 10:11, PIRS stock has moved up by 10.40% at $4.15. The stock has traded 50 million shares, below its average volume of 6.06 million shares. The stock opened at $5.01 and moved in a range of $ 4.0800 – 5.0900.
PIRS Released News Yesterday
Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Genentech
- PIRS announced it has entered into a multi-program research collaboration and license agreement with Genentech, a member of the Roche Group, to discover, develop and commercialize locally delivered respiratory and ophthalmology therapies that leverage Pieris’ proprietary Anticalin® technology.
- The research collaboration will enable Pieris to combine its robust discovery engine with Genentech’s targets, as well as its preclinical and clinical development expertise, to create novel therapies for the treatment of respiratory and ophthalmological diseases. These two focus areas of the collaboration are uniquely suited to the advantages offered by the small size of Anticalin proteins when delivered locally.
|+/- EMA(20)||2.34 (+78.63%)|
|+/- SMA(50)||2.33 (+79.40%)|
|+/- SMA(200)||2.60 (+60.77%)|